Jason Haas

Director of Finance/CFO at ODYSSEY THERAPEUTICS, INC.

Net worth: 3 M $ as of 2026-06-29

58 year

69 connections

Health Technology

Finance

Consumer Services

Profile

Jason Haas is currently an Independent Director at Ligand Pharmaceuticals, Inc. since 2022 and Chief Financial Officer at Odyssey Therapeutics, Inc. since 2024.
Formerly, Mr. Haas was Chief Financial Officer at Syros Pharmaceuticals, Inc. from 2021 to 2024, Co-Head-Americas & Healthcare Investment Banking at Barclays PLC from 2016 to 2021, Head-Americas & Healthcare Investment Banking at Deutsche Bank AG from 2012 to 2016, and Managing Director at Goldman Sachs & Co. LLC.
Education includes an undergraduate degree from Colgate University and an MBA from Columbia Business School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LIGAND PHARMACEUTICALS INCORPORATED 0.02%	2026-06-11	4,981 ( 0.02% )	2 M $	2026-06-29
ODYSSEY THERAPEUTICS, INC. 0.13%	2026-05-07	62,908 ( 0.13% )	1 M $	2026-06-29

Jason Haas active positions

Companies	Position	Start
LIGAND PHARMACEUTICALS INCORPORATED	Director/Board Member	2022-06-28
ODYSSEY THERAPEUTICS, INC.	Director of Finance/CFO	2024-11-30

All active positions of Jason Haas

Former positions of Jason Haas

Companies	Position	End
SYROS PHARMACEUTICALS, INC.	Director of Finance/CFO	2024-11-21
BARCLAYS PLC	Corporate Officer/Principal	2021-09-30
DEUTSCHE BANK AG	Corporate Officer/Principal	2016-05-31
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	-

See the detail of Jason Haas's experience

Training of Jason Haas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jason Haas's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Ligand Pharmaceuticals, Inc. Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies	Health Technology
Deutsche Bank AG Deutsche Bank AG Investment Banks/BrokersFinance Provides investment and corporate banking & asset management services	Finance
Barclays PLC Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services	Finance
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Colgate University Colgate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies	Health Technology
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Odyssey Therapeutics, Inc. Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases	Health Technology